Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet regimen for treating HIV infection. This medication integrates three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by preventing the HIV's ability to multiply within the body, remarkably reducing the viral burden. F